Clinical Trial Update: Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of bortezomib and thalidomide in newly diagnosed Stage II or Stage III multiple myeloma; results were posted in July …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-23